Phathom Pharmaceuticals (PHAT) Fair Value & DCF

PHAT$6.06-0.17 -2.73%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$492.63MEnterprise value$445.13MRevenue (TTM)$274.88MMarket position—

Score

68
Bullish
Value
60
Quality
44
Growth
100

Phathom Pharmaceuticals, Inc. (PHAT) trades at $6.06 on $492.63M of equity value, with a trailing P/E of -5.51. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Phathom Pharmaceuticals (PHAT) Fair Value & DCF

PHAT price $6.06 -0.17 -2.73%

Ticker
PHAT
Price
$6.06
Change
-0.17 -2.73%
Market cap
$492.63M
Forward P/E
7.73
Dividend yield
0.00%
Beta
0.50
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
60
Quality
44
Growth
100

Stocklytics score rationale: value 60, quality 44, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener